Stocks
Praxis Precision Medicines, Inc.PRAX
NASDAQHealthcareBiotechnology$291.19
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for central nervous system disorders, including epilepsy and movement disorders. Its pipeline targets genetically defined patient populations, and investors track it for upcoming clinical data readouts and regulatory milestones.
52W Range: $50.23-$392.70
Congressional Interest in Praxis Precision Medicines, Inc. (PRAX)
2 members of Congress have disclosed 2 trades in Praxis Precision Medicines, Inc. (PRAX), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
2
Sells
0
Who in Congress Is Trading PRAX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-07-30 | Gilbert Cisneros | buy | $1K-$15K |
| 2021-02-24 | MICHAEL T. MCCAUL | buy | $1K-$15K |